[Coagulation factor IX inhibitor in hemophilia B].
An inhibitor against blood clotting factor IX was observed as a very rare finding in case of an eight year old boy suffering from haemophilia B. By reason of a haemarthros a replacement therapy was successful done using FEIBA (Factor Eight Inhibitor Bypassing Activity). The haemostatic characterization of the inhibitor and its influence by therapy will be presented.
Lutze
G
G
Institut für Klinische Chemie und Laboratoriumsdiagnostik, Medizinischen Akademie Magdeburg.
Mittler
U
U
Presser
H J
HJ
Urbahn
H
H
D002648:Child; D005164:Factor IX / Q000037:antagonists & inhibitors*; D002836:Hemophilia B / Q000628:therapy*; D006487:Hemostasis; D006801:Humans; D008297:Male
D005164:Factor IX
Gerinnungsfaktor-IX-Inhibitor bei Hämophilie B.